DEFINITIVE PROXY STATEMENT

Company

BIOMARIN PHARMACEUTICAL INC

Filed

April 11, 2023

Accession Number

0001308179-23-000635

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →